EUVIMEDEUVIMED entdecken
Crossref

Corydalis decumbens and tetrahydropalmatrubin inhibit macrophages inflammation to relieve rheumatoid arthritis by targeting Fosl2

Peng Gao, Shuo Yuan, Yanhang Wang, Yuqi Wang, Xiaoshuang Li, Tingting Liu, Yongzhe Zheng, Jing Wang, Dan Liu, Luzheng Xu, Yong Jiang, Kewu Zeng und 1 weitere

Journal of Ethnopharmacology · 2025-02 · 341 · 119348

DOI: 10.1016/j.jep.2025.119348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025-02. Verfasst von Peng Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. Hauptthemen laut MEDLINE: Corydalis, Arthritis, Rheumatoid, Macrophages, Fos-Related Antigen-2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Corydalisdecumbens (Thunb.) (CD) is a traditional Chinese medicine and as a single herb or formula has been used to treat RA for decades. Rheumatoid arthritis (RA) is a persistent, systemic autoimmune inflammatory disease. However, the anti-inflammatory target, effective constituents and mechanism was unclear. AIM OF THE STUDY: The purpose of this study was to identify anti-RA and anti-inflammatory targets of CD, elucidate effective constituents and molecular pharmacological mechanism. MATERIALS AND METHODS: Anti-RA and anti-inflammatory effect of CD were evaluated on CIA-rats and in LPS-induced RAW264.7 cells respectively. The anti-inflammatory target of CD was identified using thermal proteome profiling (TPP). The recombinant Fosl2 protein was expressed and purified and the target-based effective constituents was screened with bio-layer interferometry (BLI) analysis. Combining photoaffinity probe, LC-MS/MS analysis, docking and point mutation, the binding site was confirmed between Fosl2 and THP. Furtherly, immunofluorescence (IF), co-immunoprecipitation (co-IP) were used to research the pharmacological mechanism of THP and the THP-influenced downstream pathways were elucidated by transcriptomics analysis. RESULTS: CD had therapeutic effect on CIA-rats and a significant anti-inflammation on macrophages. Fosl2 was identified as a target of CD and we elucidated the target-based effective constituents was protoberberine-type alkaloids. THP can inhibit inflammation and transcription of AP-1 via targeting Fosl2 on LPS-induced RAW264.7 cells. For mechanism, THP promoted Fosl2 nuclear translocating and interacting with c-Jun. CONCLUSIONS: These findings firstly elucidated the target and effective constituents of CD treating RA, and found that "undruggable target" Fosl2 can be used as therapeutic targets for RA. Meanwhile, our research suggested that THP has a significant potential for the treatment of RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CorydalisArthritis, RheumatoidMacrophagesFos-Related Antigen-2Anti-Inflammatory AgentsBerberine AlkaloidsArthritis, ExperimentalAnimalsRAW 264.7 CellsMiceRatsMaleHumansLipopolysaccharides

Stichwörter der Autor:innen

Corydalis decumbensFosl2Rheumatoid arthritisTarget identificationTetrahydropalmatrubin

Substanzen

Fos-Related Antigen-2Anti-Inflammatory AgentsBerberine AlkaloidsFosl2 protein, mouseLipopolysaccharides

Autor:innen und Institutionen

  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
  • Medical and Healthy Analytical Center, Peking University Health Science Center, Beijing, 100191, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. Electronic address: yongjiang@bjmu.edu.cn.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. Electronic address: ZKW@bjmu.edu.cn.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. Electronic address: pengfeitu@bjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gao, P., Yuan, S., Wang, Y., Wang, Y., Li, X., Liu, T., Zheng, Y., Wang, J., Liu, D., Xu, L., Jiang, Y., Zeng, K., & Tu, P. (2025). Corydalis decumbens and tetrahydropalmatrubin inhibit macrophages inflammation to relieve rheumatoid arthritis by targeting Fosl2. Journal of Ethnopharmacology, 341, 119348. https://doi.org/10.1016/j.jep.2025.119348

Vancouver

Gao P, Yuan S, Wang Y, Wang Y, Li X, Liu T, et al. Corydalis decumbens and tetrahydropalmatrubin inhibit macrophages inflammation to relieve rheumatoid arthritis by targeting Fosl2. Journal of Ethnopharmacology. 2025;341:119348. doi:10.1016/j.jep.2025.119348

BibTeX
@article{Gao2025,
  author = {Gao, Peng and Yuan, Shuo and Wang, Yanhang and Wang, Yuqi and Li, Xiaoshuang and Liu, Tingting and Zheng, Yongzhe and Wang, Jing and Liu, Dan and Xu, Luzheng and Jiang, Yong and Zeng, Kewu and Tu, Pengfei},
  title = {Corydalis decumbens and tetrahydropalmatrubin inhibit macrophages inflammation to relieve rheumatoid arthritis by targeting Fosl2},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  volume = {341},
  pages = {119348},
  doi = {10.1016/j.jep.2025.119348}
}
Kostenlos starten →